Note: This is an IPO of 13.095 million American Depositary Shares (ADS). Each ADS represents one ordinary share. We are an artificial intelligence-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Our goal is to change the pharmaceutical industry’s underlying pharmacoeconomic model, what we […]

We are a clinical stage biopharmaceutical company using our proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. We are initially focusing […]

We are an autonomous vehicle (AV) technology company that is focused on addressing industrial uses for autonomous vehicles. We believe that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbent vehicle manufacturers, and […]

Note: Both Reuters and The Wall Street Journal estimate that FWD Group Holdings’ IPO could raise $2 billion to $3 billion. (FWD Group Holdings is incorporated in the Cayman Islands) Our vision is changing the way people feel about insurance. We are a fast-growing and leading Pan-Asian life insurer with a customer-led, legacy-light and digital-first model.   […]

(Note: Yesway withdrew its IPO plans in an SEC filing dated Nov. 30, 2022. The S-1 was filed on Sept. 21, 2021.) Yesway is one of the fastest-growing convenience store operators in the U.S., with 403 company-operated stores as of June 30, 2021, up from 140 as of Dec. 31, 2018. We operate our portfolio […]

We intend to focus our search on companies that operate in the Latin American markets. (Incorporated in the Cayman Islands) We believe that the Latin American region holds a diverse base of numerous public ready businesses seeking capital to fund their operations and achieve long-term growth. However, most companies in the region face hurdles in […]

(Note: Healthcare Triangle downsized its IPO at pricing on Oct. 12, 2021, to 3.3 million shares, down from 4.6 million in the prospectus, and priced the stock at $4 – the bottom of its $4-to-$5 price range – to raise $13 million. On Thursday, Oct. 7, 2021, Healthcare Triangle downsized its IPO to 4.6 million […]

We intend to focus our search on domestically based businesses within the direct selling industry with enterprise values from $500 million to $2.0 billion. Dave Wentz serves as the chairman and CEO of Direct Selling Acquisition Corp. He is the former CEO of USANA Health Sciences, Inc. (NYSE: USNA), a direct seller of science-based nutritional and personal care […]

We are a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). We believe that our lead products, the EsoGuard® Esophageal DNA Test […]

We intend to focus on businesses in the media/entertainment/sports industry, including “over-the-top” digital streaming, mobile gaming/interactive entertainment, digital media including advertising/marketing technology, health and wellness/lifestyle, live events/experiential consumer-facing technology, and related industries which can capitalize on our management team’s expertise. Our management team is led by Joseph R. Ianniello, our CEO and chairman, and Marc […]